Language selection

Search

Patent 1084500 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1084500
(21) Application Number: 257086
(54) English Title: METHOD FOR PREPARING ORTHO-AMINOBUTYROPHENONE DERIVATIVES AND SALTS THEREOF
(54) French Title: DERIVES ET LEURS SELS D'O-AMINOBUTYROPHENONE
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/267.2
  • 260/279.2
  • 260/292.2
  • 260/278.5
(51) International Patent Classification (IPC):
  • C07D 211/32 (2006.01)
  • C07D 211/14 (2006.01)
  • C07D 211/18 (2006.01)
  • C07D 211/52 (2006.01)
  • C07D 295/108 (2006.01)
  • C07D 295/12 (2006.01)
  • C07D 307/33 (2006.01)
  • C07D 317/16 (2006.01)
  • C07D 471/10 (2006.01)
(72) Inventors :
  • SASAJIMA, KIKUO (Japan)
  • ONO, KEIICHI (Japan)
  • MOTOIKE, YASUO (Japan)
  • INABA, SHIGEHO (Japan)
  • YAMAMOTO, HISAO (Japan)
(73) Owners :
  • SUMITOMO CHEMICAL CO., LTD. (Japan)
(71) Applicants :
(74) Agent: KIRBY EADES GALE BAKER
(74) Associate agent:
(45) Issued: 1980-08-26
(22) Filed Date: 1976-07-15
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
88473/1975 Japan 1975-07-18
87962/1975 Japan 1975-07-17

Abstracts

English Abstract




Abstract of the Disclosure:
Novel compounds of the formula:
Image
wherein R is a hydrogen of fluorine atom, W is an oxygen
atom or an ethylenedioxy or ethylenedithio group and Z is a
certain secondary amino group, which are useful as central
nervous system depressants, can be prepared by the reaction
of a compound of the formula:
Image
wherein X is a halogen atom and R and W are each as defined
above with a secondary amine of the Formula: N-Z wherein Z
is as defined above, in case of W being ethylenedioxy or
ethylenedithio, optionally followed by hydrolysis and can be
reduced to give a compound of the formula:
Image
wherein R and Z are each as defined above, which are known to
be useful as antipsychotic and/or analgesic agents.


- 1 -


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:
1. A process for preparing .gamma.-(secondary amino)-
ortho-nitrobutyrophenone compounds of the formula:


Image


wherein R is a hydrogen atom or a fluorine atom, W is an
oxygen atom, an ethylenedioxy group or an ethylenedithio
group and Z is a secondary amino group of any one of the
formulas:


Image ; Image ;




Image ; Image ;



and

Image


(wherein Ar is a phenyl group or such group substituted with
one or two substituents selected from the group consisting
of halogen, methyl, methoxy and trifluoromethyl, R1 is a
hydrogen atom or a hydroxyl group, R2 is a hydrogen atom or
a halogen atom and R3 is a hydrogen atom or a methoxy group),
and their salts, which comprises reacting a compound of the
formula:

29

Image


wherein X is a halogen atom and R and W are each as defined
above with a secondary amine of the formula:
H-Z
wherein Z is as defined above, and when required, hydrolysing
products in which W is ethylenedioxy or ethylenedithio to form
products in which W is oxygen and when the pharmaceutically
acceptable salts are required, reacting the products obtained
above with corresponding organic or inorganic acids.
2. The process according to claim 1, wherein the
reaction is carried out in the presence of an acid binding
agent.
3. The process according to claim 2, wherein the
acid binding agent is an inorganic base or a tertiary amine.
4. The process according to claim 2, wherein the
reaction is carried out in an inert solvent.
5. The process according to claim 2, wherein the
reaction is carried out at a temperature from room tempera-
ture to the refluxing temperature of the reaction system.
6. The process according to claim 1, wherein the
starting compound is the one prepared by reacting a compound
of the formula:


Image


wherein Q is a halogen atom or an alkoxycarbonyloxy group of the
-formula: -O-CO-OR4 (wherein R4 is a C1-C3 alkyl group) and R is
a hydrogen atom or a fluorine atom, with a compound of the formula:



Image

wherein R5 is a C1-C3 alkyl group, optionally
followed by deacylation to give a compound of the formula:


Image

wherein R is as defined above and reacting the latter with
a hydrohalogenic acid of the formula:
H-X
wherein X is as defined in claim 3 optionally followed by
ketalization.
7. The process according to claim 6 wherein the first
essential reaction is carried out in the presence of a
base.
8. The process according to claim 7 wherein the base
is an alkali metal or alkaline earth metal alkoxide, an
alkali metal hydride, an alkali metal amide, an alkali
metal salt of triphenylmethane, an organic lithium com-
pound or an alkali metal methylsulfinyl carbanion.
9. The process according to claim 7 wherein the reac-
tion is carried out in an inert solvent.
10. The process according to claim 6 wherein the deacyl-
ation is carried out by treatment with an alkali in a
suitable solvent.
11. The process according to claim 6 wherein the ketal-
ization is carried out by treatment with ethylene glycol
or ethylene dithioglycol in the presence of an acid
catalyst in an inert solvent.

31

12. A compound of the formula:


Image


wherein R is a hydrogen atom or a fluorine atom, W is an
oxygen atom, an ethylenedioxy group or an ethylenedithio
group and Z is a secondary amino group of either one of the
formulas:


Image ; Image ;


Image ; Image ;




and
Image


(wherein Ar is a phenyl group or such group substituted with one
or two substituents selected from the group consisting of
halogen, methyl, methoxy and trifluoromethyl, R1 is a hydrogen
atom or a hydroxyl group, R2 is a hydrogen atom or a halogen
atom and R3 is a hydrogen atom or a methoxy group), or its
pharmaceutically acceptable acid addition salts, whenever
produced to the process according to claim 1 or an obvious
chemical equivalent.

32

Description

Note: Descriptions are shown in the official language in which they were submitted.


1084S00
,, - ~
.
This invention relates to an improved process for
producing ortho-aminobutyrophenone derivatives and their : :
salts, which are known to be useful as antipsychotic and/or .
analgesic agents, and to novel ortho-nitrobutyrophenone
derivatives and their salts, which are intermediates in the
said process and per se useful as central nervous system
depressants.
The said ortho-aminobutyrophenone derivatives are .
. representable by the formula:



R ~ C-c772c732c7~2-z II]

NH2
wherein R is a hydrogen atom or a fluorine atom and Z is a
secondary amino group of any one of the formulas: `;`. :
o(R ~R


;',''~ :
(a) (b)


-N~N~II 7
.




(c) (d)

R3
and -N N~
\_J '

(e)

- 2 - . .

~ `' ` ' ~ . .

1~84500
[wherein Ar is a phenyl group optionally substituted with
one or two substituents selected from the group consisting
of halogen (e.g. chlorine, bromine, fluorine), methyl,
methoxy and trifluoromethyl; Rl is a hydrogen atom or a
hydroxyl group; R2 is a hydrogen atom or a halogen atom
(e.g. chlorine, bromine, fluorine); and R3 is a hydrogen
atom or a methoxy group].
The said novel ortho-nitrobutyrophenone derivatives,
which are claimed as one aspect of this invention, include
Y-(secondary amino)-ortho-nitrobutyrophenones of the
formula:

R ~ C-CH2CH2CH2-z [II]

: N2 ~: .
wherein R and Z are each as defined above and their ketals
of the formula:

R ~ C-CH2CH2CH2-z [II']
. ,
N02
wherein Y is an ethylenedioxy group or an ethylenedithio -~
group and R and Z are each as defined above.
The y-(secondary amino)-ortho-aminobutyrophenones
lI] and the methods for producing them are well known in -
20 the literature [cf. Belgian patents 753,472 and 796,893].
However, extensive investigations have been made in
order to find an alternative and advantageous process for
preparing the y-~secondary amino)-ortho-aminobutyro-
phenones [I]. As a result, a novel and commercially
advantageous process has now been established.
'; .
- 3 -
~1 '.
~ .

~.

~ , ~ .- - '

~C)84SOO
-- The y-(secondary amino)-ortho-aminobutyrophenone ::
[I] can be prepared from the corresponding y-(secondary
amino)-ortho-nitrobutyrophenone [II] or its ketal [II']
by reduction thereof and in case of the ketal, with
previous or subsequent hydrolysis. When the pharmaceu-
tically acceptable salts are required, the products thus :
obtained are reacted with the corresponding organic or .. .
inorganic acids.
According to the present invention, the y-(second-
ary amino)-ortho-nitrobutyrophenone [II] and its ketal
[II'], which are novel compounds, are advantageously
'-, ~'''

. - .
",,:

',..';', :




- 3a -
-- .


. ~ .

- - 10~4S00

prepared by reacting the corresponding y-(halo)-ortho-
nitrobutyrophenone of the formula:

R ~C-CH2CH2CH2--X [III¦

2
wherein X is a halogen atom (e.g. chlorine, bromine) and R
is as defined above or its ketal with a secondary amine of
the formula:
H-Z
wherein Z is as defined above. In case of the ketal, the
reaction is optionally followed by hydrolysis. When the
pharmaceutically acceptable salts are required, the pro- ~
ducts thus obtained may be reacted with the corresponding ~ -
organic or inorganic acids.
The ~-(halo)-ortho-nitrobutyrophenone [III] and its
ketal, which are also novel, can be produced advantageously
by reacting an ortho-nitrobenzoic acid derivative of the
formula: o
R ~ C-Q lIV]
1 '
N2 ' .:
wherein Q is a halogen atom (e.g. chlorine, bromine) or a

O
group of the formula: -o-C-oR4 (wherein R4 is a Cl-C3
~alkyl group (e.g. methyl, ethyl, and propyl)) and R is as
defined above with an a_(alkanoyl)-~-butyrolactone of the
formula: O
R5 - C- ~ O [V]
:, . . .
O
wherein R5 is a Cl-C3 alkyl group (e.g. methyl, ethyl,

- 4 -




;, . ... ~ .:, . ~ . .

- 10~34S00

~ propyl) to give the corresponding a-(ortho-nitrobenzoYl)-y-
butyrolactone derivative of the formula:

R ~ C ~ O [VI]

N2 1
wherein R is as defined above and/or the corresponding
a-(alkanoyl)-a~krtho-nitrobenzoyl)-y-butyrolactone deri-
vative of the formula:
coR5 ;

R ~ C ~ O [VIII

N2 ,. .
wherein R and R5 are each as defined above and, in case of .~ :
the a,a-(diacyl)-y-butyrolactone [VII] being produced, . :~:
10 deacylating the same to the corresponding a-(acyl)-y-butyro-~ :
lactone lVI], followed by reaction with a hydrohalogenic
acid of the formula:
H-X
wherein X i8 as defined above to give the corresponding y-
(halo)-ortho-nitrobutyrophenone [III], which may be op-
tionally ketalized to give the corresponding ketal.
The sequential steps from the ortho-nitrobenzoic
acid derivative [IV] and the a-(alkanoyl)-y-butyrolactone :
[V] through the y-(halo)-ortho-nitrobutyrophenone [III] or
its ketal and the y-(secondary amino)-ortho-nitrobutyro-
phenone [II] or its ketal to the y-(secondary amino)-ortho-
aminobutyrophenone [I] as stated above are representable by
the following schema:


. .

~.~ ':.
- . . . . - . . . ~ . . -. . . . . . .- . . .-. . :

1084500

Sche~a A
.

R ~ C-Q + R5 C ~ O
~,
N2
[IV] l [V] ' ,
~..

COR5 : .
~8~\ t1any R ~ C ~ O

[VI] [VII]
H-X

O ' y
P~B-CH2CH2CH2-X, ktei,Onl,iZ,a R~C-CH2CH2CH2-X , ~ , ,.
N2 2
[III] lIII']
H-Z H-Z .

hydrolysi ~ Il_CH CH CH Z ;~

NO2 2 ~ .
[II] [II']
reduction reduction
.~ , ' '~ , .' ''.
O y
R ~ C-CH2CH2CH2-Z <~hydrolysis R_ ~ -C CH2CH2CH2 Z

NH2 2
[I] [I']

-- 6 --



~'

-^ 1084500

.
wherein R, 2, Y, Z, r~ and Q are each as defined a~ove.

In the above schema, the conversion in the latter
two stages can be summarized by the following formulas: - ; -



R ~ C-cN2cH2cN2-x ~ R ~ C-CN2CN2CN2-Z ~ ~
. . . .
N02 N2
[IIIA] 1IIA]

reduction ~ ~ C-CH CH -Z
R ~ 2CH2 2 .

NH2 .,
[ I A ]
wherein W is an oxygen atom, an ethylenedioxy group or an

ethylenedithio group and R, X and Z are each as defined
.
above.
The production of ~-(halo)-ortho-nitrobutyxo-
phenone derivatives by nitration of the corresponding ~-
(halo)-butyrophenone derivatives, of which the conversion is
representable by the following formulas, is known [cf. U.S.
patent 3,562,277]: ' ;


R~-CN2CH2CN2-X' R7_~C-CH2CN2CN2-X'

R6 R6 N2

wherein X' is a halogen atom and R6 to R9 are each a
hydrogen atom or a lower alkoxy group, at least one of R6 to
R9 being a hydrogen atom, or any two adjacent members of R6




.. ~
F~

--- 1084Soo ~:

to R9 taken together form a methylenedioxy group. Adoption
of such nitration in the production of the r- (halo)-ortho-
nitrobutyrophenone [III], however, is apparently disadvan-
tageous, because the main nitration product is the undesired
; meta-nitrated compound [cf. British patent 943,7391.
In the present invention, an entirely different
route is recommended to produce the Y-(halo)-ortho-nitro-
butyrophenone [lII] in a good yield. Thus, it may be
produced from the ortho-nitrobenzoic acid derivative [IV]
and the ~-(alkanoyl)-~-butyrolactone [V] through the ~-
(ortho-nitrobenzoyl)-y-butyrolactone [VI] as stated above.
The process of the present invention will be
illustrated below in detail according to the sequence of
the reaction steps.
Step 1
Production of the ~-(ortho-nitrobenzoyl)-y-

,: :. . .
butyrolactone [VI]:-
The reaction of the ortho-nitrobenzoic acid
derivative [IV] with the a-~alkanoyl)-~-butyrolactone tV] is
usually carried out in the presence of a base in an inert
solvent. As the base, there may be used an alkali metal or;
alkaline earth metal alkoxide (e.g. sodium alkoxide,
potassium alkoxide, magnesium alkoxide), an alkali metal
hydride (e.g. sodium hydride, potassium hydride, lithium
hydride), an alkali metal amide (e.g. sodium amide, potassium
amide, lithium dialkylamide), an alkali metal salt of
triphenylmèthane, an organic lithium compound (e.g. n-butyl
lithium! phenyl lithium), an alkali metal methylsulfinyl
~arbanion, etc. Examples of the inert solvent include
ethers (e.g. diethyl ether, 1,2-dimethoxyethane, tetra-

.


~ '

.

1084500 ;~ ~hydrofuran), aromatic hydrocarbons (e.g. benzene, toluene) -~
and aprotic polar solvents (e.g. dimethylformamide, dimethyl
sulfoxide, hexamethylene phosphoramide). Although various
combinations of the base and the solvent may be employed in
this reaction, it is preferable to use a magnesium alkoxide
(e.g. magnesium methoxide, magnesium ethoxide) or an alkali
metal hydride (e.g. sodium hydride) in an inert solvent such
as an e*her and an aromatic hydrocarbon.
Among the ortho-nitrobenzoic acid derivatives
~IV], the use of one wherein Q is chlorine, bromine or
ethoxycarbonyloxy is preferred. As the a-(alkanoyl)-
y-butyrolactone [V], the use of a-acetyl-y-butyrolactone is
favorable, since it is commercially available.
For the practical procedure of the reaction, the
-(alkanoyl)-y-butyrolactone tV] may first be treated with
the base to form the carbanion or enol anion, which is then
subjected to treatment with the ortho-nitrobenzoic acid
derivative [IV]. The proportion of the ortho-nitrobenzoic
acid derivative [IV] and the a-(alkanoyl)-y-butyrolactone
~V] is usually 0.2 - 2 : 1 in molar ratio. The amount
of the base to be used can be decided appropriately depend-
ing on its kind. When, for instance, magnesium alkoxide is
used as the base, the molar ratio of the a-(alkanoyl)-y-
butyrolactone [Vl to the base may be from 1 to 3.
As the result of the reaction, there are produced
the a-(acyl)-y-butyrolactone [VI] and/or the a,~-(diacyl)-y-
butyrolactone [VII]. By adoption of suitable reaction
and/or isolation conditions, either one of them may be obtained
predominantly or solely. When the ~ (diacyl) -r- butyro-
lactone [VII] is obtained as the main product, it




_ 9 _

~ ',
~'.

- 10~450~) -
may be converted into the corresponding -(acyl)-y-butyro-
lactone [VI] by deacylation. The deacylation can be ac- -
!,- complished by treatment with an alkali such as ammonia, an
alkali metal hydroxide, an alkali metal carbonate or an
alkali metal bicarbonate in a suitable solvent such as water
~, or an alkanol. For instance, the a, a- (diacyl)-y-butyro-
lactone [VII] may be shaken with a dilute aqueous ammonium
-~ hydroxide solution in the presence of a water-immiscible
organic solvent at room temperature for a few minutes to
give the corresponding a- (acyl)-y-butyrolactone [VI].
Specific examples of the a-(acyl)-y-butyrolactone
tVIl are a- (4-fluoro-2-nitrobenzoyl)-y-butyrolactone and
i a- (2-nitrobenzoyl)-y-butyrolactone.
Step 2
; Production of the y-(halo)-ortho-nitrobutyro-
phenone [III] and its ketal [III']~
The a- (acyl)-y-butyrolactone [VI] can be readily
converted into the corresponding y-~halo)-ortho-nitrobutyro-
phenone [III] by reacting with a hydrohalogenic acid ~e.g.
hydrochloric acid, hydrobromic acid, hydroiodic acid). The
j reaction is usually carried out by keeping a mixture of
. the a- ~acyl)-y-butyrolactone [VI] and the hydrohalogenic
op~;onq//y
~_J acid, r~o~orabl~ in an inert solvent such as an ether, an
aromatic hydrocarbon or a ketone at an elevated temperature
above room temperature, particularly above 50C. While the
hydrohalogenic acid may be employed in a not less than
equimolar amount to the a- (acyl)-~-butyrolactone [VI], the
use of a larger amount,such as three or more equivalents,can
accelerate the progress of the reaction.
The thus produced y-(halo)-ortho-nitrobutyro-

;i
-- 1 0
.~ , .

~ ' .

1084500

phenone [III] may be recovered from the reaction mixture by
a conventional separation procedure, for instance, extrac-
tion with a suitable solvent and concentration of the
extract.
Conversion of the y-(halo)-ortho-nitrobutyro- -~
phenone [III] into its ketal [III'] may be carried out in a
per se conventional ketalization procedure, for instance, by
treatment with ethylene glycol or ethylene dithioglycol in
- the presence of an acid catalyst such as p-toluenesulfonic
10 acid, sulfuric acid, hydrogen chloride or Lewis acid (e.g. ;
boron trifluoride, stannic chloride) in a suitable inert
solvent. The water by-produced in the reaction may be
eliminated from the reaction system by various procedures,
of which examples are azeotropic distillation with a water-
immiscible organic solvent, slow distillation in vacuo,
¦ treatment with a Lewis acid catalyst, treatment with a
scavenger such as an ortho ester (e.g. ethyl ortho-formate),
ethylene sulfite or molecular sieves.
Specific examples of the y-~halo)-ortho-nitro-
~; 20 butyrophenone tIIIl and its ketal lIII'] are y-chloro-4-
3 fluoro-2-nitrobutyrophenone, y-bromo-4-fluoro-2-nitro-
butyrophenone, y-iodo-4-fluoro-2-nitrobutyrophenone,
y-chloro-2-nitrobutyrophenone, y-bromo-2-nitrobutyrophenone,
, . .
f~ r-iodo-2-nitrobutyrophenone, 4-chloro-1-(4-fluoro-2-nitro-
phenyl)-l,l-ethylenedioxy-n-butane, 4-bromo-1-(4-fluoro-2-
nitrophenyl)-l,l-ethylenedioxy-n-butane, 4-chloro-1-(2-
nitrophenyl)-l,l-ethylenedioxy-n-butane, 4-bromo-1-(2-
nitrophenyl)-l,l-ethylenedioxy-n-butane~
Step 3
Production of the y-(secondary amino)-ortho-

-- 11 --

~ 84500

nitrobutyrophenone lII] and its ketal [II']:-

The y-(halo)-ortho-nitrobutyrophenone [III] and
its ketal [III'] can be respectively converted into the
corresponding r- (secondary amino)-ortho-nitrobutyrophenone
[II] and its ketal lII'] by reaction of the former with the
secondary amine (H-Z). The reaction may be effected in the
presence of an acid binding agent such as an inorganic base
(e.g. potassium carbonate, sodium carbonate, sodium bi-
carbonate) or a tertiary amine (e.g. pyridine, triethyl-

amine, dimethylaniline) in the presence or absence of asuitable solvent. Examples of the suitable solvent are an
amide (e.g. dimethylformamide, dimethylacetamide, form-
amide), an aromatic hydrocarbon (e.g. benzene, toluene,
xylene), an alkanone (e.g. acetone, methyl ethyl ketone,
methyl isobutyl ketone), an ether ~e.g. tetrahydrofuran,
dioxane), an alkanol (e.g. ethanol, propanol, butanol), etc.
The reaction can be conducted at a wide range of temperature
from room temperature to the refluxing temperature of the
reaction system, and a higher temperature is generally
preferred. When, however, the ketal [II'] is subjected to
the reaction, somewhat a milder condition, for example, a
temperature below 90C is favorable.
Hydrolysis of the ketal [II'] into the y-
~secondary amino)-ortho-nitrobutyrophenone [II] may be
accomplished by a per se conventional procedure. For
example, it can be conducted by treatment with a mineral
acid (e.g. hydrochloric acid, sulfuric acid, phosphoric
acid), an organic acid (e.g. oxalic acid, tartaric acid)
or an acidic ion exchange resin in water or an alkanol (e.g.
methanol, ethanoI, propanol). The cleavage of the ketal




- 12 -

~P
: .. .
. ' '' ~ - , , .

o84500
group can also be effected by exchange with acetone in the : :~ -
presence of a mineral acid, and such cleavage is facilitated
in the presence of periodic açid.
. Specific examples of the y-(secondary amino)-
ortho-nitrobutyrophenone [II] and its ketal [II'] are as
,. .. .
follows:
y-[4-Hydroxy-4-(3-trifluoromethylphenyl)piperi-
dino]-4-fluoro-2-nitrobutyrophenone;
y-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4-
fluoro-2-nitrobutyrophenone;
, y-[4-(4-Chloro-3-trifluoromethylphenyl)-4-hydroxy-
: piperidino]-4-fluoro-2-nitrobutyrophenone;
~, y-14-(3,4-Dichlorophenyl)-4-hydroxypiperidino]-4-
,' fluoro-2-nitrobutyrophenone; -.
Y-[4-(3-Chloro-4-methylphenyl)-4-hydroxypiperi-
:~ dino]-4-fluoro-2-nitrobutyrophenone;
,~ ~
;~ r-(4-Phenylpiperidino)-4-fluoro-2-nitrobutyro-.,;~ .
:~ phenone;

;~ Y-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-

.20 yl)-4-fluoro-2-nitrobutyrophenone;

-[4-(2-Oxo-l-benzimidazolinyl)piperidino]-4-

fluoro-2-nitrobutyrophenone;

" y-[4-(4-Chlorobenzyl)-4-hydroxypiperidino]-4-
,
i fluoro-2-nitrobutyrophenone;
y-[4-(2-Methoxyphenyl~piperazino]-4-fluoro-2

nitrobutyrophenone;
y-[4-Hydroxy-4-(4-methylphenyl)piperidino]-4-fluoro-
' 2-nitrobutyrophenone;
, y-[g-Hydroxy-4-(4-methoxyphenyl)piperidino~-g-fluoro-
2-nitrobutyrophenone;
, y-[4-Hydroxy-4-(3-trifluoromethylphenyl~piperidino]- .
. 2-nitrobutyrophenone; .
., .
.~ ' .
- 13 - ~

.. ~," ~' '.

084500
y-[4-(4-Chlorophenyl)-4-hydroxypiperidino~-2-
. nitrobutyrophenone;
y-(4-Benzyl-4-hydroxypiperidino)-2-nitrobutyro-

phenone; :
y-[4-(4-Chlorobenzyl)-4-hydroxypiperidino]-2-

~ nitrobutyrophenone; :
: y-[4-(4- hloro-3-trifluoromethylphenyl)-4-hydroxy-
piperidino]-2-nitrobutyrophenone;
,~ y-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-
:' 10 yl)-2-nitrobutyrophenone;
y-[4-(2-Oxo-l-benzimidazolinyl)piperidino]-2-
nitrobutyrophenone;
~ y-[4-~2-Methoxyphenyl)piperazino]-2-nitrobutyro-
phenone;
4-[4-Hydroxy-4-(3-trifluoromethylphenyl)piperi-
dino]-l-(4-fluoro-2-nitrophenyl)-l,l-ethylenedioxy-n-butane;
.:, 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-l-(4-
fluoro-2-nitrophenyl)-l,l-ethylenedioxy-n-butane;
4-[4-(4-Chloro~3-trifluoromethylphenyl)-4-hydroxy-
piperidino~-1-(4-fluoro-2-nitrophenyl)-l,l-ethylenedioxy-n-

, butane;
4-~4-Oxo-l-phenyl~1,3,8-triazaspiro~4,5~decan-8-yl)-
1-(4-fluoro-2-nitrophenyl)-1,1-ethylenedioxy-n-butane;
4-[4-(2-Oxo-l-benzimidazolinyl)piperidino~-l-(4-
fluoro-2-nitrophenyl)-l,l-ethylenedioxy-n-butane.
The thus prepared ~-(secondary amino)-ortho-nitro-
, butyrophenone lII] or its ketal [II'] can be readily I
converted into its inorganic or organic acid addition salts
by a per se conventional procedure. Examples of such salt~

30 include pharmaceutically acceptable ones such as hydro-
chloride, hydrobromide, sulfate, phosphate, sulfamate,
citrate, oxalate, lactate, maleate, malate, succinate,
tartra~e, cinnamate, acetate, benzoate, gluconate, ascor-
~ 14 -
'~9

, . . .

10~45()0
, . ~.
..... ~ . ~`
bate, fumarate, glutamate, salicylate and the like. ~-
The y-(secondary amino)-ortho-nitrobutyrophenone [II]
and its ketal [II'] and their acid addition salts thus
obtained have useful central nervous system depressive
activities. Some ortho-nitrobutyrophenone compounds
similar to them are disclosed in U.S. patent 3,562,277,
but in the specification of this patent, it is stated that
those y-(piperazino)-ortho-nitrobutyrophenones have less
central nervous system activity. The y -(secondary amino)-
ortho-nitrobutyrophenone [II] and its ketal lII'] and their
acid addition salts of the present invention have been
found to exert various central nervous system depressive
activities in the standard screening tests in animals and
are useful as medicaments such as antipsychotics, seda-
tives, tranquilizers and analgesics. The Y-(secondary
~; amino)-ortho-nitro-para-fluorobutyrophenone [II: R =
fluorine] and its acid addition salts are the most prefer-
able ones as antipsychotics and superior to Chlorpromazine.
These compounds of this invention are useful in causing
depression of the central nervous sy8tem of mammals in a
daily dose of about 0.5 to 300 mg per os.
SteP 4
Production of the Y-(secondary amino)-ortho-amino-
butyrophenone [I] and its ketal [I']:-
Reduction of the Y-(secondary amino)-orthonitrobutyro-
phenone [II] and its ketal [II'] afford respectively the
Y-(secondary amino)-ortho-aminobutyrophenone [I]`and its
ketal [I']. The y-(secondary amino)-ortho-nitrobutyro-
phenone [II] or its ketal [II'] may be subjected to the
.. ..
reduction in the form of a free base or an acid addition
salt.
- 15 - ~-
' .':

10845

- Although various reducing agents and systems which have
heretofore been adopted for conversion of a nitro group
into an amino group, such as treatment with a metal or its
salt in the presence of an acid or an alkali, treatment
with an alkali sulfide or polysulfide in the presence of
an alkali or catalytic hydrogenation, are applicable for
accomplishment of the reduction in this step, preferable
are treatment with a metal (e.g. iron, tin, zinc) or its
salt (e.g. stannous chloride) in the presence of an acid
~e.g. hydrochloric acid, sulfuric acid, acetic acid) or
catalytic hydrogenation using as the catalyst palladium
on charcoal, nickel or the like.
Preferably, the reduction is carried out in the pres-
ence of an inert solvent such as water, an alkanol (e.g.
methanol, ethanol, propanol), an aromatic hydrocarbon
(e.g. benzene, toluene), an alkanone (e.g. acétone, methyl
ethyl ketone) or an ether (e.g. tetrahydrofuran, dioxane).
The hydrogenation is preferbly conducted in the presence
of palladium on charcoal in a Cl-C3 alkanol and, in most
cases, proceeds readily at room temperature under atmos-
pheric pressure of hydrogen.
In case of the ketal ~II'] being subjected to the
reduction, there are produced the y-(secondary amino)-
ortho-aminobutyrophenone [I] and/or its ketal lI'] depend-
ing on the reaction conditions. When the ketal [I'l is
produced, it can be converted into the corresponding
y-(secondary amino)-ortho-aminobutyrophenone [I] by
hydrolysis in substantially the same manner as described
in Step 3.
Recovery of the y-(secondary amino)-ortho-amino-
butyrophenone [I] and/or its ketal [I'] from the reaction
mixture may be achieved by application of a conventional
- 16 -

'

~084500
procedure for separation and purification.
Specific examples of the y-(secondary amino)-
ortho-aminobutyrophenone [I] and its ketal [I'] are as
follows: .
y-[4-Hydroxy-4-(3-trifluoromethylphenyl)piperi-
dinol-2-amino-4-fluorobutyrophenone;
y-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-2- :
amino-4-fluorobutyrophenone;
y-[4-(4-Chloro-3-trifluoromethylphenyl)-4-hydroxy-
piperidino]-2-amino-4-fluorobutyrophenone;
y-[4-(3,4-Dichlorophenyl)-4-hydroxypiperidino]-2-
amino-4-fluorobutyrophenone;
y-[4-(3-Chloro-4-methylphenyl)piperidino]-2-amino- .
4-fluorobutyrophenone;
y-(4-Phenylpiperidino)-2-amino-4-fluorobutyro-
phenone;
y-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-
yl~-2-amino-4-fluorobutyrophenone; . .
y-[4-(2-Oxo-l-benzimidazolinyl)piperidinol-2-
amino-4-fluorobutyrophenone;
y-[4-(4-Chlorobenzyl)-4-hydroxypiperidino~-2- ;
amino-4-1uorobutyrophenone;
y-[4-(2-Methoxyphenyl)piperazinol-2-amino-4- . .
fluorobutyrophenone; :
. .
y-[4-Hydroxy-4-(4-methylphenyl)piperidino]-2-
amino-4-fluorobutyrophenone;
y-(4-Benzyl-4-hydroxypiperidino)-2-aminobutyro- -.
phenone;
y-l4-(4-Chlorobenzyl)-4-hydroxypiperidino]-2
aminobutyrophenone;




- 17 -

~ .

~-- ~084500
4-Oxo-l-phenyl-1~3,8-triazaspiro~4,5]decan-8-yl)-
2-aminobutyrophenone;
4-~4-Hydroxy-4-(3-trifluoromethylphenyl)piperidino]-
1-(2-amino-4-fluorophenyl~-1,1-ethylenedioxy-n-butane;
4-[4-(3,4-Dichlorophenyl~-4-hydroxypiperidino~-1-
(2-amino-4-fluorophenyl)-1,1-ethylenedio~y-n-butane;
4-~4-(3-Chloro-4-methylphenyll-4-hydroxypiperidino]-
1-(2-amino-4-fluorophenyl)-1,1-ethylenedioxy-n-butane;
4-(4-Oxo-l-phenyl-1,3,8-triazaspiro~4,5]decan-8-yl)-

1-(2-amino-~-fluorophenyl)-1,1-ethylenedioxy-n-butane;
4-l4-(2-Oxo-l-benzinidazolinyl)piperidino]-1-(2-
amino-4-fluorophenyl)-l,l ethylenedioxy-n-butane.
The thus prepared y-(secondary amino)-ortho-amino-
butyrophenone [I] or its ketal [I'] can be readily converted
into its inorganic or organic acid addition salts as
exemplified in Step 3 by a conventional procedure.
As stated above, the y-(secondary amino)-ortho-
aminobutyrophenone [I] and its acid addition salts are known
to be useful as antipsychotic and/or analgesic agent8.
Practical and presently prefarred embodiment8 of
the invention are illustratively shown in the following
examples without limiting the scope of the invention in
any way.




- 18 -

~ ' , .~ ,;~ .

~ 84500
.
-- Example 1
(A) A mixture of 8.0 g of magnesium turnings, 33
g of anhydrous ethanol and 3 ml of carbon tetrachloride was
allowed to react on standing for several minutes. After the
exothermic reaction had subsided, 250 ml of anhydrous
toluene was slowly added with stirring, and the reaction
mixture was stirred at 30 - 35C for additional 3 hours. To
the resulting suspension of magnesium ethoxide, a solution
of 84.6 g of a-acetyl-y-butyrolactone in 100 ml of anhydrous -
toluene was added dropwise with cooling at 0 - 5C. After
the resulting mixture was stirred at room temperature for
one hour, crude 4-fluoro-2-nitrobenzoyl chloride, prepared
from 55.5 g of 4-fluoro-2-nitrobenzoic acid and 170 ml of
thionyl chloride, in 100 ml of anhydrou~ toluene was added
dropwise at 20 - 25C and stirred for an additional 3 hours.
After 700 ml of 5 % sulfuric acid was added to the resulting
mixture with cooling in an ice-salt bath, the organic
layer was separated, and the aqueous layer was extracted
with portions of toluene. The resulting organic layer ;
contained a-acetyl-a-~4-fluoro-2-nitrobenzoyl)-y-butyro-
lactone as the main product. The combined organic layer was !' ' '
washed with water and saturated aqueous sodium chloride
solution and extracted with three portions of cold 5 %
aqueous ammonium hydroxide solution. The combined aqueous
ammonium hydroxide layer was washed with toluene and acidi-
fied by the slow addition of 25 ~ sulfuric acid with cooling.
The precipitated solid was collected by filtration, washed
with water and dried to give 63.5 g (83.6 %) of a-(4-
fluoro-2-nitrobenzoyl)-y-butyrolactone. M.P. 87 - 89C.
(B) Using an equimolar amount of magnesium


-- 19 --

~ .
.. ., . .. ., . . ~ . ,

.~ , - - , . . .. .. . . . . .

1~84SOO

ethoxide instead of the one prepared from magnesium in
ethanol in (A), the same product was also obtained in a
yield of 79.3 ~. M.P. 86.5 - 89.0C.
(C) A mixture of 16.2 g of magnesium turnings,
67.5 g of anhydrous ethanol and 5 ml of carbon tetrachloride
was allowed to react on standing for several minutes. After
the exothermic reaction had subsided, 500 ml of anhydrous
toluene was slowly added with stirring, and the resulting
mixture was stirred at 35 - 40C for an additional 2 hours. To
the resulting mixture, a solution of ~-acetyl-y-butyrolactone
(170.8 g) in anhydrous toluene (200 ml) was added thereto
dropwise with cooling below 10C, and the resultant mixture
was stirred at room temperature for one hour. A solution of
o-nitrobenzoyl chloride, prepared from 100 g of the corre-
sponding acid, in anhydrous toluene (200 ml) was added
thereto dropwise at 20 - 25C, and stirring was carried out
for an additional 2 hours. With cooling, 1.4 liters of 5 %
sulfuric acid was slowly added to the reæulting mixture, and
the whole was extracted with ethyl ac~tate (900 ml). The
aqueous layer WA9 extracted with two portions of toluene-
ethyl acetate (1 : 1), and the combined extracts were washed
with water and aqueous saturated sodium chloride solution
and extracted with three portions of cold 5 % aqueous
ammonium hydroxide solution (840 g x 3). The
combined aqueous layer was washed with toluene and acidified
with 25 % sulfuric acid with cooling. The precipitated
crystals were collected by filtration, washed with water and




- 20

~':, ';

. :: . : . ,, . . - .. ~ . . .

1084500

dried to give 120 g (85 %) of ~-(2-nitrobenzoyl)-y-butyro-
lactone. M.P. 75 - 76C.
Example 2
(A) A mixture of 20.0 g of -(4-fluoro-2-nitro- -
benzoyl)-y-butyrolactone and 66.6 g of hydrobromic acid (d =
1.48) was warmed at 85C until the evolutlon of carbon
dioxide ceased. After warming for additional 30 minutes,
the reaction mixture was diluted with 300 ml of cold water
and extracted with toluene. The extracts were washed with
water, dried over anhydrous sodium sulfate and concentrated
under reduced pressure to yield 21.7 g (95 %) of y-bromo-4- ;~
,: - , . . .
fluoro-2-nitrobutyrophenone as an oil. B.P. 139 - 148C (at

0.18 - 0.20 mmHg).

(B) A mixture of 5.06 g of a-(4-fluoro-2-nitro-

benzoyl)-y-butyrolactone and 20 ml of concentrated hydro- ;
. . .
chloric acid was treated as in (A) to give 4.4 g (90 %) of
y-chloro-4-fluoro-2-nitrobutyrophenone. B.P. 132.0 -
132.5C (at 0.17 - 0.19 mmHg).
~C) In the same manner as above, y-bromo-2-nitro-

butyrophenone and y-chloro-2-nitrobutyrophenone were obtained
in good purity and high yield.
Example 3
~ A) A mixture of 2.9 g of y-bromo-4-fluoro-2-
nitrobutyrophenone, 1.25 g of ethylene glycol, 2.2 g of
ethylene sulfite, 0.38 g of p-toluenesulfonic acid mono-
hydrate and 20 m~ of toluene was heated under reflux for

9 hours. After cooling, the reaction mixture was diluted
with 40`ml of 5 % aqueous sodium hydroxide solution, and the
toluene layer was separated. The aqueous layer was extracted
with toluene, and the combined organic layer was washed with
E~' ` ' .
- ` 21


. ~
.

11~84SOO
.

water, dried over anhydrous sodium sulfate and concentrated
under reduced pressure to yield 3.l g of 4-bromo-l-(4-
fluoro-2-nitrophenyl)-l,l-ethylenedioxy-n-butane as an oil.
; (B) A mixture of 117 g of y-bromo-4-fluoro-2-
nitrobutyrophenone, 50 g of ethylene glycol, 7.7 g of p-
toluenesulfonic acid monohydrate and 500 ml of benzene was
; heated under reflux for 60 hours, during which the water
produced was eliminated as an azeotropic mixture by the use
of the Dean-Starke's apparatus. After cooling, the reaction
mixture was washed with water and diluted aqueous sodium
bicarbonate solution, dried over anhydrous sodium sulfate
and concentrated under reduced pressure to yield 135 g of 4-

; bromo-1-(4-fluoro-2-nitrophenyl)-1,1-ethylenedioxy-n-butane
as an oil. B.P. 135 - 140C (at 0.17 mmHg).

~ (C) In the same manner as above, 4-bromo-1-(2-'
nitrophenyl)-l,l-ethylenedioxy-n-butane and 4-chloro-1-(2-
i nitrophenyl)-l,l-ethylenedioxy-n-butane were obtained.
Example 4
~A) A mixture of 3~7 g of 4-bromo-l-(~-fluoro-2-
nitrophenyl)-l,l-ehtylenedioxy-n-butane, 2,5 g of 4-hydroxy-
4-(3-trifluoromethylphenyl)piperidine, 1.4 g o anhydrous
potassium carbonate, a catalytic amount of potassium iodide
and 20 ml of methyl isobutyl ketone was heated at 80 - 90C
for 2 hours. After cooling, the reaction mixture was
diluted with 100 ml of water and extracted with ethyl
acetate. The extracts were washed with water and aqueous
saturated sodium chloride solution, dried over anhydrous
sodium sulfate and concentrated under reduced pressure to

yield 4-14-hydroxy-4-(3-trifluoromethylphenyl)piperidino]-1-
(4-fluoro-2-nitrophenyl)-1,1-ethylenedioxy-n-butane as a



~ 2 2 ~:

,: ~ . - ' .

` ~ ~

~' ~084~00

residual oil.
. .~ .
~ (B) The residual oil was dissolved in a mixture
;,;
of 27.5 g of isopropanol and 27.5 g of 20 ~ hydrochloric

'- acid and heated under reflux for one hour. After
.. ~ . , .
i~ concentrating under reduced pressure, the precipitated solid
~}1:
~; was recrystallized from isopropanol to yield 2.8 g of Y-14-
,~;
i~ hydroxy-4-(3-trifluoromethylphenyl)piperidino]-4-fluoro-2-
~ .; . .
nitrobutyrophenone hydrochloride as crystals. M.P. 209 -
210.5C. A second crop (0.5 g) was obtained from the
mother liquor, M.P. 205 - 209C. The free base was obtained by
the conventional procedure, M.P. 109 - 112C (from aqueous
ethanol).
Example 5
. A mixture of 9.4 g of y-bromo-4-fluoro-2-nitro-
butyrophenone, 7.1 g of 4-hydroxy-4-(3-trifluoromethyl-
phenyl)piperidine, 4.0 g of potassium carbonate, a catalytic
amount of potassium iodide and 60 ml of toluene was stirred
at room temperature for 10 hours. The resulting mixture was
diluted with water and extracted with toluene-ethyl ace~ate
(1 : 1), and the organic layer was extracted with cold 30 %
hydrochloric acid. The hydrochloric acid layer was washed
with toluene, made alkaline with 20 % aqueous sodium
hydroxide solution with cooling and extracted with ethyl
acetate. The extracts were washed with water, dried over
anhydrous sodium sulfate and concentrated to yield 6.4 g

; of ~-[4-hydroxy-4-(3-trifluoromethylphenyl)piperidino]-4-
fluoro-2-nitrobutyrophenone as a residual oil, which was
i~ converted into its hydrochloride by a conventional manner.
B M.P. 200 - 20~C.
EXa

,~ j "
~ . 23 : :~

~' ' `".
,. . .

1084500
.. . , `
,.,
- (A) A mixture of 4-bromo-1-(4-fluoro-2-nitro-phenyl)-1,
:,.,;
;` l-ethylenedioxy-n-butane (3.3 g), 4-hydroxy-4-(3-trifluoro-
methylphenyl)piperidine (1.96 g), potassium carbonate
- (1.1 g), potassium iodide (20 mg) and methyl isobutyl
;- ketone (25 g) was heated under reflux for one hour. To the
, .
;: resulting mixture, 13 % hydrochloric acid (8.2 g) was added
with cooling, and the precipitated crystals were collected
.i,.,:, .
;~ by filtration, washed with toluene and dried to give 3.9 g
(91.1 %) of 4-[4-hydroxy-4-(3-trifluoromethylphenyl)
piperidino]-1-(4-fluoro-2-nitrophenyl)-1,1-ethylenedioxy-
,, ,:
~ n-butane hydrochloride. M.P. 229C (decomp.).
¦ (B) A mixture of the ethylenedioxy compound obtained
, above (1.87 g), 15 % hydrochloric acid (17.1 g) and ethanol
.;.,
s~ (13 g) was heated under reflux for one hour, concentrated
'i under atmospheric pressure and cooled with an ice-salt bath
~ for one hour. The precipitated crystals were collected by
, ....
il filtration to give 1.6 g (93 %) of Y-[4-hydroxy-4-(3-
.... .
;i trifluoromethylphenyl)piperidino]-4-fluoro-2-nitrobutyro-
phenone hydrochloride. M.P. 209C.
,~r,.,l 20 Example 7
il In a similar manner to Example 4, 5 or 6, the fol- '
.~ lowing y-(secondary amino)-o-nitrobutyrophenones were
,l obtained by the use of a suitable secondary amine in place
,; of 4-hydroxy-4,3-trifluoromethylphenylpiperidine:
y-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4-fluoro-2-
~i`! nitrobutyrophenone hydrochloride, M.P. 199.5 - 202C;
~!1 y-[4-(4-Chloro-3-trifluoromethylphenyl)-4-hydroxy-
; piperidono]-4-fluoro-2-nitrobutyrophenone, M.P. 144.5 -

t' i 146.5C; hydrochloride, M.P. 248C (decomp.);
.j,~, .
, j, . .. .
~ - 24 -


.
.. ~ -

1084500 ~.
- ~ y-[4-(3,4-Dichlorophenyl)-4-hydroxypiperidino]-4-
fluoro-2-nitrobutyrophenone hydrochloride, M.P. 211.5 -
212.5C;
y-[4-(3-Chloro-4-methylphenyl)-4-hydroxypiperi-
dino]-4-fluoro-2-nitrobutyrophenone hydrochloride, M.P.
236.5C (decomp.);
y-(4-Phenylpiperidino)-4-fluoro-2-nitrobutyro-
phenone hydrochloride, M.P. 178 - 188C;
; y-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-
yl)-4-fluoro-2-nitrobutyrophenone hydrochloride, M.P. 228 -
j~ 229C;
y-[4-(2-Oxo-l-benzimidazolinyl)piperidino]-4-
fluoro-2-nitrobutyrophenone, M.P. 138 - 142C;
r- [4-(4-Chlorobenzyl)-4-hydroxypiperidino]-4-
fluoro-2-nitrobutyrophenone hydrochloride, M.P. 210C
(decomp.);
y-[4-(2-Methoxypheny~piperazino]-4-fluoro-2-
nitrobutyrophenone hydrochloride, M.P. 206C (decomp.);
r- [4-~ydroxy-4-(4-methylphenyl)piperidine]-4
J 20 fluoro-2~nitrobutyrophenone, etc.
J Example 8
By substituting 4-bromo-1-(2-nitrophenyl)-1,1-
I ethylenedioxy-n-butane for 4-bromo-1-(4-fluoro-2-nitro-
;1 phenyl)-l,l-ethylenedioxy-n-butane in Example 4, 5, 6 or 7,
the following compounds were obtained:

1 y-[4-Hydroxy-4-(3-trifluoromethylphenyl)piperi-
dino]-2-nitrobutyrophenone;
y-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-2-
~ nitrobutyrophenone;

'i 30 y-(4-Benzyl-4-hydroxypiperidino)-2-nitrobutyro-
.1 .
2~
, . . .
:, .

. ~ .
~ , ~ . .

1~)84SOO
phenone;
' y-[4-~4-Chlorobenzyl)-4-hydroxypiperidino]-2- ;'
~' nitrobutyrophenone;
~, y-14-(4-Chloro-3-trifluoromethylphenyl)-4-hydroxy-
piperidino]-2-nitrobutyrophenone;
~' y-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-
~;~ yl)-2-nitrobutyrophenone; '
'~ y-[4-(2-Oxo-l-benzimidazolinyl)piperidino]-2-
~ nitrobutyrophenone;
.. ~
y-[4-(2-Methoxyphenyl)piperazino]-2-nitrobutyro-
phenone, etc.
,,; Example 9 -~
A mixture of 4.9 g of y-[4-hydroxy-4-~3-trifluoro-
methylphenyl)piperidino]-4-fluoro-2-nitrobutyrophenone
~; hydrochloride, 1.0 g of 5 % palladium on charcoal (50 %
wet reagent) and 80 g of methanol was vigorously stirred in a
hydrogen atmosphere at room temperature until the theoretical
.. ; ., .
'') amount of hydrogen was consumed. The catalyst was filtered
~;~ off and washed with hot methanol, and the filtrate was
"'I .
4l 20 concentrated under reduced pressure. The residuai solid was
triturated with isopropanol, collected by filteration and ~ '
wa6hed with diisopropyl ether to afford 3.9 g of y-[4-
'" hydroxy~4-(3-trifluoromethylphenyl)piperidino]-2-amino-4- ''~
,.~ ,
~ fluorobutyrophenone monohydrochloride. M.P. 202 - 204C. '''
"1 The free base of this product was obtained by the conven-
tional procedure. M.P. 106 - 107C (recrystallized from
~; toluene). '
:, Example 10 -
A mixture of 4-[4-hydroxy-4-(3-trifluoromethyl-
phenyl)piperidino]-1-(4-fluoro-2-nitrophenyl)-1,1-ethylene-
I , ~
` 2 6 ::


`.;

J84500

~ dioxy-n-butane (6.42 g), water (20 g), ethanol (80 g) and
;.,.:. -: :
~; concentrated hydrochloric acid (1.4 g) was warmed to 70C. ~ -

Iron powder (6.7 g) was added portionwise to the mixture and

~;~ gently refluxed for one hour. After the precipitate was ~-
. ~.......................................... . .
;~ filtered off and washed with hot ethanol, the filtrate was
concentrated in vacuo. The residue was made alkaline with
10 % aqueous sodium hydroxide solution and the whole was
extracted with ethyl acetate. The extract was washed with
water, dried over anhydrous sodium sulfate and evaporated
under reduced pressure. The residue was dissolved in
isopropanol ~25 g), and concentrated hydrochloric acid (5 g)
was added thereto with cooling. The precipitated crystals
were collected by filtration, washed with toluene and dried
to yield 4.4 g (80 %) of y-[4-hydroxy-4-(3-trifluoromethyl-


?~!; .
phenyl)piperidino]-2-amino-4-fluorobutyrophenone monohydro-
chloride. M.P. 208.5 - 209.5C.
Example 11
By substituting y-14-hydroxy-4-~3-trifluoromethyl-
phenyl)piperidino]-4-fluoro-2-nitrobutyrophenone hydro-
chloride for 4-[4-hydroxy-4-(3-trifluoromethylphenyl)~
~1 ; . " '
~ piperidino]-1-(4-fluoro-2-nitrophenyl)-1,1-ethylenedioxy-n-
'i~,l
butane in Example 10, the same product was obtained.
~;! ! Exampl~ 12
In a similar manner to Example 9 or 10, the follo~-

ing o-aminobutyrophenone compounds were obtained:
y-[4-~4-Chlorophenyl)-4-hydroxypiperidino]-2-

amino-4-fluorobutyrophenone hydrochloride, M.P. 235C
i~' (decomp.);

-~4-(4-Chloro-3-trifluoromethylphenyl)-4-hydroxy-
; 30 piperidlno]-2-amino-4-fluorobutyrophenone, M.P. 166 - 167C;
'; . .
B~ 27
, ~ . . ~ .
,`', ~ . ~' .

~ 84500

y-[4-(3,4-Dichlorophenyl)-4-hydroxypiperidino]-2-
amino-4-fluorobutyrophenone hydrochloride, M.P. 214 -
214.5C;
y-[4-(3-Chloro-4-methylphenyl)piperidino]-2-amino-
4-fluorobutyrophenone hydrochloride, M.P. 207 - 210C;
r- (4-Phenylpiperidino)-2-amino-4-fluorobutyro-
phenone hydrochloride, M.P. about 185C;
y-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-
yl)-2-amino-4-fluorobutyrophenone, M.P. 198C;
y-[4-(2-Oxo-l-benzimidazolinyl)piperidinol-2-
amino-4-fluorobutyrophenone, M.P. 230 - 235C;
y-[4-(4-Chlorobenzyl)-4-hydroxypiperidino]-2-
amino-4-fluorobutyrophenone hydrochloride, M.P. 155C
(decomp,);
y-[4-(2-Methoxyphenyl)piperazino]-2-amino-4-
fluorobutyrophenone, M.P. 83 - 87C;
Y-14-Hydroxy-4-(4-methylphenyl)piperidino]-2-
amino-4-fluorobutyrophenone, M.P. 140C;
r- (4-Benzyl-4-hydroxypiperidino)-2-aminobutyro-
phenone, M.P. 123C;
y-14-(4-Chlorobenzyl)-4-hydroxypiperidino]-2-
aminobutyrophenone, M.P. 138C;
r-(4-Oxo-l-phenyl-1,3,8-triazaspiro[4,5]decan-8-
yl)-2-aminobutyrophenone, M.P. 180C, etc. ~;-


: ' .
-


- ~.




28




~
,.
... . . ~ . . ~ .. .. . . ..

Representative Drawing

Sorry, the representative drawing for patent document number 1084500 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1980-08-26
(22) Filed 1976-07-15
(45) Issued 1980-08-26
Expired 1997-08-26

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1976-07-15
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
SUMITOMO CHEMICAL CO., LTD.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-04-07 1 8
Claims 1994-04-07 4 124
Abstract 1994-04-07 1 51
Cover Page 1994-04-07 1 17
Description 1994-04-07 28 1,079